GlobalData Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increa

$ 4450


MediPoint: Total Ankle Replacement - US Analysis and Market Forecasts Summary Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly seeking ou

$ 4450


MediPoint: Total Ankle Replacement - EU Analysis and Market Forecasts Summary Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly seeking ou

$ 4450


MediPoint: Total Ankle Replacement - South America Analysis and Market Forecasts Summary Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly

$ 4450


MediPoint: Total Ankle Replacement - APAC Analysis and Market Forecasts Summary Ankle arthritis is a severe and debilitating problem with notable increasing prevalence in both the developed and developing world. In a society constantly seeking

$ 4450


EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022 Summary Respiratory syncytial virus (RSV) is one of the most common causes of respiratory infections in child

$ 3995


MediPoint: Predictive Breast Cancer Gene Testing - Current and Future Players Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the i

$ 3500


MediPoint: Total Ankle Replacement - Current and Future Players Summary GlobalData has released its medical devices report, “MediPoint: Total Ankle Replacement - Current and Future Players”. The report is an essential source of information and

$ 3500


GlobalData has released its new PharmaPoint Drug Evaluation report, Protelos (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 an...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Forteo (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and ...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Reclast (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Evista (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and ...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Actonel (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Aprela (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and ...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Romosozumab (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Odanacatib (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 ...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and ...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 201...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Ostora (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and ...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Recalbon/Bonoteo (Osteoporosis) - Forecast and Market Analysis to 2022. Despite its maturity, the osteoporosis market is expected to undergo substantial change between...

$ 3495

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from GlobalData. We have market research reports of all sectors covered by the GlobalData; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100